BFI Infinity Ltd. Takes $3.06 Million Position in McKesson Corporation $MCK

BFI Infinity Ltd. bought a new position in McKesson Corporation (NYSE:MCK) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 3,725 shares of the company’s stock, valued at approximately $3,056,000. McKesson makes up 1.9% of BFI Infinity Ltd.’s investment portfolio, making the stock its 12th largest holding.

Several other hedge funds have also bought and sold shares of MCK. USA Financial Formulas bought a new stake in McKesson during the 4th quarter valued at $136,000. Mechanics Bank Trust Department raised its holdings in McKesson by 11.2% during the fourth quarter. Mechanics Bank Trust Department now owns 4,444 shares of the company’s stock worth $3,645,000 after buying an additional 449 shares during the last quarter. Wealthcare Advisory Partners LLC lifted its stake in shares of McKesson by 0.7% in the fourth quarter. Wealthcare Advisory Partners LLC now owns 1,873 shares of the company’s stock valued at $1,536,000 after buying an additional 13 shares in the last quarter. Pallas Capital Advisors LLC lifted its stake in shares of McKesson by 3.6% in the fourth quarter. Pallas Capital Advisors LLC now owns 3,348 shares of the company’s stock valued at $2,746,000 after buying an additional 115 shares in the last quarter. Finally, Elevatus Welath Management acquired a new position in shares of McKesson during the fourth quarter valued at about $223,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Transactions at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michele Lau sold 2,725 shares of McKesson stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the sale, the executive vice president owned 3,247 shares in the company, valued at $3,214,530. This trade represents a 45.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 3,868 shares of company stock worth $3,743,820. 0.08% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms have recently commented on MCK. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. Barclays raised their price target on shares of McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research report on Wednesday, February 18th. Leerink Partners reiterated an “outperform” rating and set a $1,085.00 price target on shares of McKesson in a research note on Thursday, March 5th. Wall Street Zen raised McKesson from a “hold” rating to a “buy” rating in a report on Sunday, March 22nd. Finally, Morgan Stanley reissued an “overweight” rating and issued a $966.00 price objective on shares of McKesson in a research note on Thursday, January 29th. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, McKesson has an average rating of “Moderate Buy” and an average target price of $960.93.

McKesson Price Performance

NYSE MCK opened at $860.41 on Friday. The company has a fifty day moving average price of $907.62 and a 200-day moving average price of $839.75. The firm has a market cap of $105.39 billion, a price-to-earnings ratio of 24.75, a PEG ratio of 1.38 and a beta of 0.38. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. During the same period last year, the firm earned $8.03 earnings per share. The firm’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, research analysts anticipate that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.